Lucid Diagnostics Inc
LUCD
Get informed when a big investor buys or sells
+ FollowMarket Cap$102.3M
Close$
$2.12
111.6% upside
Current Fair Value
111.6% upsideUndervalued by 111.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $102.30 Million |
|---|---|
| Enterprise Value | $101.23 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.69 |
| Beta | 1.07 |
| Outstanding Shares | 101,947,000 |
Return
| Return on Equity | -2023565.10% |
|---|---|
| Return on Assets | -237507.64% |
| Return on Invested Capital | -222056.61% |
Valuation & Multiples
| P/E Ratio | -2.15 |
|---|---|
| PEG | 2.15 |
| Price to Sales | 0.02 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.02 |
| Enterprise Value to EBIT | -0.01 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.26 |
| Debt to Equity | 6.7 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 18, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
$1.40 M
Average shareholder expectationNext Earnings Call
Expected Date
August 12, 2026
EPS Estimate
$-0.04
Average shareholder expectationRevenue Estimate
$1.43 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 34.94%▲ 5.19% |
|---|---|
| Total Invested | $40.96M▲ 16.62% |
| Investors Holding | 103▲ 14.00% |
ESG Score
No data